Background: Metagenomic next-generation sequencing (mNGS) is a powerful method for pathogen detection. In this study, we assessed the value of mNGS for bronchoalveolar lavage (BAL) samples in the diagnosis of pulmonary infections. Methods: From February 2018 to April 2019, BAL samples were collected from 235 patients with suspected pulmonary infections. mNGS and microbial culture were performed to evaluate the effectiveness of mNGS in pulmonary infection diagnosis. Results: We employed mNGS to evaluate the alpha diversity, results suggesting that patients with confirmed pathogens had a lower microbial diversity index compared to that of patients with uncertain pathogens. For the patients admitted to the respiratory intensive care unit (RICU) or on a ventilator, they experienced a lower diversity index than that of the patients in the general ward or not on a ventilator. In addition, mNGS of BAL had a diagnostic sensitivity of 88.89% and a specificity of 14.86% in pulmonary infection, with 21.16% positive predictive value (PPV) and 83.87% negative predictive value (NPV). When rare pathogens were excluded, the sensitivity of mNGS decreased to 73.33%, and the specificity increased to 41.71%. For patients in the simple pulmonary infection group and the immunocompromised group, the main infection types were bacterial infection (58.33%) and mixed-infection (43.18%). Furthermore, mNGS had an advantage over culture in describing polymicrobial ecosystem, demonstrating the microbial distribution and the dominant strains of the respiratory tract in patients with different underlying diseases. Conclusions: The study indicated that mNGS of BAL samples could provide more accurate diagnostic information in pulmonary infections and demonstrate the changes of respiratory microbiome in different underlying diseases. This method might play an important role in the clinical use of antimicrobial agents in the future.
Background: Metagenomic next-generation sequencing (mNGS) is a powerful method for pathogen detection. In this study, we assessed the value of mNGS for bronchoalveolar lavage (BAL) samples in the diagnosis of pulmonary infections. Methods: From February 2018 to April 2019, BAL samples were collected from 235 patients with suspected pulmonary infections. mNGS and microbial culture were performed to evaluate the effectiveness of mNGS in pulmonary infection diagnosis. Results: We employed mNGS to evaluate the alpha diversity, results suggesting that patients with confirmed pathogens had a lower microbial diversity index compared to that of patients with uncertain pathogens. For the patients admitted to the respiratory intensive care unit (RICU) or on a ventilator, they experienced a lower diversity index than that of the patients in the general ward or not on a ventilator. In addition, mNGS of BAL had a diagnostic sensitivity of 88.89% and a specificity of 14.86% in pulmonary infection, with 21.16% positive predictive value (PPV) and 83.87% negative predictive value (NPV). When rare pathogens were excluded, the sensitivity of mNGS decreased to 73.33%, and the specificity increased to 41.71%. For patients in the simple pulmonary infection group and the immunocompromised group, the main infection types were bacterial infection (58.33%) and mixed-infection (43.18%). Furthermore, mNGS had an advantage over culture in describing polymicrobial ecosystem, demonstrating the microbial distribution and the dominant strains of the respiratory tract in patients with different underlying diseases. Conclusions: The study indicated that mNGS of BAL samples could provide more accurate diagnostic information in pulmonary infections and demonstrate the changes of respiratory microbiome in different underlying diseases. This method might play an important role in the clinical use of antimicrobial agents in the future.
Authors: Emily S Charlson; Kyle Bittinger; Andrew R Haas; Ayannah S Fitzgerald; Ian Frank; Anjana Yadav; Frederic D Bushman; Ronald G Collman Journal: Am J Respir Crit Care Med Date: 2011-06-16 Impact factor: 21.405
Authors: J A Scott; A J Hall; C Muyodi; B Lowe; M Ross; B Chohan; K Mandaliya; E Getambu; F Gleeson; F Drobniewski; K Marsh Journal: Lancet Date: 2000-04-08 Impact factor: 79.321
Authors: Michael R Wilson; Hannah A Sample; Kelsey C Zorn; Shaun Arevalo; Guixia Yu; John Neuhaus; Scot Federman; Doug Stryke; Benjamin Briggs; Charles Langelier; Amy Berger; Vanja Douglas; S Andrew Josephson; Felicia C Chow; Brent D Fulton; Joseph L DeRisi; Jeffrey M Gelfand; Samia N Naccache; Jeffrey Bender; Jennifer Dien Bard; Jamie Murkey; Magrit Carlson; Paul M Vespa; Tara Vijayan; Paul R Allyn; Shelley Campeau; Romney M Humphries; Jeffrey D Klausner; Czarina D Ganzon; Fatemeh Memar; Nicolle A Ocampo; Lara L Zimmermann; Stuart H Cohen; Christopher R Polage; Roberta L DeBiasi; Barbara Haller; Ronald Dallas; Gabriela Maron; Randall Hayden; Kevin Messacar; Samuel R Dominguez; Steve Miller; Charles Y Chiu Journal: N Engl J Med Date: 2019-06-13 Impact factor: 91.245
Authors: Jiangchao Zhao; Patrick D Schloss; Linda M Kalikin; Lisa A Carmody; Bridget K Foster; Joseph F Petrosino; James D Cavalcoli; Donald R VanDevanter; Susan Murray; Jun Z Li; Vincent B Young; John J LiPuma Journal: Proc Natl Acad Sci U S A Date: 2012-03-26 Impact factor: 11.205
Authors: Michael R Wilson; Samia N Naccache; Erik Samayoa; Mark Biagtan; Hiba Bashir; Guixia Yu; Shahriar M Salamat; Sneha Somasekar; Scot Federman; Steve Miller; Robert Sokolic; Elizabeth Garabedian; Fabio Candotti; Rebecca H Buckley; Kurt D Reed; Teresa L Meyer; Christine M Seroogy; Renee Galloway; Sheryl L Henderson; James E Gern; Joseph L DeRisi; Charles Y Chiu Journal: N Engl J Med Date: 2014-06-04 Impact factor: 91.245
Authors: Markus Hilty; Conor Burke; Helder Pedro; Paul Cardenas; Andy Bush; Cara Bossley; Jane Davies; Aaron Ervine; Len Poulter; Lior Pachter; Miriam F Moffatt; William O C Cookson Journal: PLoS One Date: 2010-01-05 Impact factor: 3.240
Authors: David C Gaston; Heather B Miller; John A Fissel; Emily Jacobs; Ethan Gough; Jiajun Wu; Eili Y Klein; Karen C Carroll; Patricia J Simner Journal: J Clin Microbiol Date: 2022-06-13 Impact factor: 11.677